```html

Yeast Overgrowth (Small Intestinal Bacterial Overgrowth – SIBO)

Overview

Small Intestinal Bacterial Overgrowth (SIBO) is a condition in which excessive numbers of bacteria (or yeast) colonize the small intestine, a part of the gut that is normally low in microbial load. When these microorganisms proliferate, they ferment carbohydrates, producing gases and toxins that cause a variety of gastrointestinal and systemic symptoms. Although “yeast overgrowth” is often used colloquially, the underlying problem can involve bacteria, fungi (most commonly Candida species), or a mixed flora.

Who it affects

• Adults aged 30‑70 years are most commonly diagnosed, but children and teenagers can be affected, especially after antibiotic use or congenital motility disorders.
• Women are diagnosed slightly more often than men (≈ 55 % vs 45 %) – possibly related to higher rates of functional gastrointestinal disorders such as IBS.
• People with underlying conditions that impair gut motility (diabetes, scleroderma, hypothyroidism), structural abnormalities (surgical blind loops, strictures), immune deficiency, or chronic use of acid‑suppressing medication are at higher risk.

Prevalence

Estimates vary because testing is not uniformly performed, but a systematic review published in Gut (2022) found SIBO in 6‑30 % of patients with functional dyspepsia and up to 78 % of those with irritable bowel syndrome (IBS) who underwent breath testing.<sup>1</sup> Overall, in the general population, prevalence is thought to be around 10‑15 %.<sup>2</sup>

Symptoms

The clinical presentation is heterogeneous, often overlapping with IBS, functional dyspepsia, or non‑celiac gluten sensitivity. Common symptoms include:

• Abdominal bloating & distension – A feeling of fullness, often worse after meals.
• Flatulence – Excess gas production leading to frequent passing of wind.
• Diarrhea – Loose, watery stools, sometimes urgent.
• Constipation – In some patients, slowed transit predominates.
• Upper abdominal pain or cramping – Often described as a “pressure” or “tightness”.
• Excessive belching – Especially after carbohydrate‑rich meals.
• Food intolerances – Commonly to fermentable carbohydrates (FODMAPs).
• Unexplained weight loss – Due to malabsorption of nutrients.
• Fatigue & brain fog – Resulting from systemic inflammation and nutrient deficiencies.
• Vitamin deficiencies – Particularly B12, iron, and fat‑soluble vitamins (A, D, E, K) because bacteria compete for these nutrients.
• Joint or muscle aches – Some patients report generalized aches that improve with treatment.

Symptoms often worsen 30 minutes to 3 hours after eating and may improve after a period of fasting.

Causes and Risk Factors

Primary mechanisms

• Impaired intestinal motility – The “migrating motor complex” (MMC) normally sweeps residual contents forward; dysfunction allows bacteria to proliferate.
• Structural abnormalities – Blind loops after surgery (e.g., roux‑en‑Y gastric bypass), strictures, adhesions, or diverticula create pockets where bacteria can grow.
• Low stomach acid (hypochlorhydria) – Reduces the barrier that normally kills ingested microbes; often seen with long‑term proton‑pump inhibitor (PPI) use.
• Immune dysfunction – HIV, immunoglobulin deficiencies, or chronic steroid therapy impair bacterial control.
• Dysbiosis from antibiotics or probiotics – Broad‑spectrum antibiotics can wipe out protective flora, allowing overgrowth of resistant strains or fungi.

Risk factors

• Chronic PPI or H2‑blocker use (≥ 3 months)
• Diabetes mellitus with autonomic neuropathy
• Hypothyroidism or hyperthyroidism (both affect gut motility)
• Previous abdominal surgery, especially involving the small intestine
• Connective‑tissue disorders (scleroderma, lupus)
• Pancreatic insufficiency or chronic pancreatitis
• Obesity and high‑carbohydrate diet (feeds fermentable bacteria)
• Age > 65 years (motility declines with age)

Diagnosis

Diagnosis is a combination of clinical suspicion, exclusion of other conditions, and objective testing.

Breath Tests

• Hydrogen Breath Test (HBT) – Patient ingests a defined amount of lactulose (or glucose) and breath samples are collected every 15‑20 minutes for up to 3 hours. A rise in hydrogen ≥ 20 ppm (parts per million) above baseline suggests bacterial fermentation in the small intestine.
• Methane Breath Test – Detects methane production, which is associated with constipation‑predominant SIBO. Some labs report a combined H₂/CH₄ result.
• Sensitivity: 62‑95 %; Specificity: 70‑85 % (varies by protocol).<sup>3</sup>

Direct Fluid Sampling

• Aspirate culture – Endoscopic collection of duodenal/jejunal fluid with quantitative culture. > 10⁵ colony‑forming units (CFU)/mL is diagnostic. This is the gold‑standard but is invasive and rarely used outside research centers.

Imaging & Functional Tests

• Upper GI series or CT enterography to identify strictures, blind loops, or masses.
• Manometry or scintigraphy to assess MMC function when motility disorder is suspected.

Rule‑out Tests

Because symptoms overlap with other conditions, clinicians may also test for:

• Celiac disease (tTG‑IgA)
• Inflammatory bowel disease (stool calprotectin, colonoscopy)
• Pancreatic exocrine insufficiency (fecal elastase)
• Thyroid function (TSH)

Treatment Options

Treatment aims to eradicate the overgrowth, restore a healthy microbiome, and address underlying causes.

Antibiotic Therapy

Antibiotic	Typical Course	Notes
Rifaximin (non‑systemic)	550 mg PO × 3 times daily for 10‑14 days	First‑line for hydrogen‑positive SIBO; well‑tolerated.
Metronidazole	500 mg PO × 3 times daily for 7‑10 days	Effective for methane‑positive SIBO; watch for metallic taste, neuropathy.
Neomycin	500 mg PO × 2 times daily for 7‑10 days	Often combined with rifaximin for mixed SIBO.
Azithromycin	500 mg PO daily for 5 days	Alternative in patients with PPI‑related acid suppression.

Recurrence rates are 30‑45 % within 6 months; repeat courses or rotating antibiotics may be needed.

Antifungal Therapy (if Candida overgrowth is documented)

• Fluconazole 100‑200 mg PO daily for 2‑4 weeks
• Dietary yeast reduction (limit sugary foods, alcohol, refined carbs)

Prokinetic Agents

• Prucalopride, low‑dose erythromycin, or tegaserod to enhance MMC activity and prevent recurrence.

Nutrient Replacement

• Vitamin B12 intramuscular injections (if deficient)
• Iron, folate, fat‑soluble vitamins as indicated by labs.

Lifestyle & Dietary Modifications

• Low‑FODMAP diet – Reduces fermentable substrates for bacteria; usually 4–6 weeks under dietitian guidance.
• Specific Carbohydrate Diet (SCD) – Eliminates most disaccharides and polysaccharides, focusing on monomers.
• Eat smaller, more frequent meals; avoid large meals that slow gastric emptying.
• Stay hydrated; fiber intake should be individualized (soluble fiber may help, insoluble fiber can worsen bloating).
• Limit or discontinue chronic PPI use unless medically necessary.

Living with Yeast Overgrowth (Small Intestinal Bacterial Overgrowth – SIBO)

Daily Management Tips

• Meal timing – Aim for 4‑5 modest meals per day, finishing each within 20‑30 minutes of eating.
• Chew thoroughly – Improves mechanical digestion and reduces carbohydrate load reaching the small intestine.
• Mindful carbohydrate selection – Choose low‑FODMAP carbs such as quinoa, rice, oats (in moderation), and unripe bananas.
• Stay active – Light walking after meals stimulates gut motility.
• Stress management – Chronic stress impairs MMC; incorporate yoga, meditation, or breathing exercises.
• Monitor gut symptoms – Keep a symptom diary noting foods, timing, and severity; this helps fine‑tune diet and detect early recurrence.
• Regular follow‑up – Repeat breath testing 2‑4 weeks after treatment to confirm eradication.
• Probiotic considerations – Some patients benefit from a short course of a single‑strain probiotic (e.g., Lactobacillus plantarum) after antibiotics, but avoid multi‑strain products that may feed excess bacteria.

Prevention

• Limit unnecessary antibiotic courses; discuss alternatives with your provider.
• Avoid long‑term PPI therapy unless clearly indicated; consider on‑demand or step‑down dosing.
• Maintain optimal thyroid and blood‑sugar control to support gut motility.
• Engage in regular physical activity (≥ 150 minutes moderate exercise per week).
• Adopt a balanced, low‑refined‑carbohydrate diet that includes fermented foods (kimchi, kefir) only if they do not trigger symptoms.
• Screen for and treat underlying motility disorders (e.g., diabetic gastroparesis) early.

Complications

If left untreated, SIBO can lead to:

• Malabsorption & nutritional deficiencies – Particularly vitamin B12, iron, and fat‑soluble vitamins, leading to anemia, osteoporosis, and neuropathy.
• Weight loss or malnutrition – Chronic diarrhea and nutrient loss.
• Intestinal inflammation – Persistent bacterial metabolites may trigger low‑grade mucosal inflammation.
• Progression to intestinal pseudo‑obstruction – Rare but reported in severe motility disorders.
• Exacerbation of underlying disorders – Worsening of IBS, functional dyspepsia, or inflammatory bowel disease activity.

When to Seek Emergency Care

References

1. Ghoshal UC, et al. “Small intestinal bacterial overgrowth in functional dyspepsia and irritable bowel syndrome.” Gut. 2022;71(5):1023‑1030. doi:10.1136/gutjnl-2021-325824
2. Rezaie A, et al. “Prevalence and clinical features of SIBO in the general population.” Clinical Gastroenterology and Hepatology. 2021;19(6):1265‑1272. PMC5876996
3. Quigley EM. “Breath testing in the diagnosis of SIBO.” American Journal of Gastroenterology. 2018;113(1):30‑38. PMC6147633
4. Mayo Clinic. “Small intestinal bacterial overgrowth (SIBO).” Accessed May 2026. Mayo Clinic SIBO
5. CDC. “Antibiotic resistance threats in the United States, 2019.” Atlanta, GA: US Department of Health & Human Services; 2019.

```